Our goal for this 5-year proposal is to further characterize the effects of exposure to 2,3,7,8-TCDD on B-cell differentiation. These studies are base don the following observations generated by our laboratory: (1) TCDD suppresses the AB response to a number of stimuli, as assessed both when TCDD and the stimulus are administered to cells from naive mice in culture, and when cells from TCDD-treated mice are immunized in culture; (2) The B- cell represents the primary target for TCDD; (3) TCDD stimulates the phosphorylation of a number of endogenous proteins in B-cells, but not T- cells; at least one protein (ie., 45 KDa) is not phosphorylated by PMA, a comparative control; (4) TCDD stimulates background kinase activity in B- cells, but not T-cells, which is not due to an activation of PKC; and (5) TCDD enhances the background AB response in the absence of any other stimulus. The primary objectives of this investigation are twofold. First, we will characterize the effects of TCDD on a defined model of B- cell maturation, in which specific factors are sequentially added to move isolated B-cells through the various stages of the cell cycle and ultimately to an AB-secreting cell. We will be particularly interested in the effects of TCDD alone on the activation and differentiation of B-cells, and will primarily address two possible mechanisms: (i) TCDD produces a profile of activity which is similar to IL4;p and (ii) TCDD causes the aberrant expression of receptors for various growth or differentiation factors. The second objective will be to further characterize the nature of the kinase system which is acrivated by TCDD and the proteins which are subsequently phosphorylated. We will specifically address whether these biochemical events are causally related to the functional defects. Our initial focus will be on the possible role by a tyrosine kinase. We believe that these studies are significant both because they will provide specific information about the site and mechanism of action of TCDD on B- cell maturation, and because they may provide a more general model for the toxic effects of TCDD on a number of other cell systems, which have been characterized by a change in the maturational state.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES002520-09
Application #
3249854
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1981-09-01
Project End
1993-02-28
Budget Start
1991-03-01
Budget End
1992-02-29
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Henriquez, Joseph; Zhou, Jiajun; Li, Jinpeng et al. (2017) Application of gene specific mRNA level determinations in individual cells using flow cytometry-based PrimeFlow™ in immunotoxicology. Toxicol Appl Pharmacol 337:39-44
Li, Jinpeng; Bhattacharya, Sudin; Zhou, Jiajun et al. (2017) Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis. J Immunol 199:3504-3515
Kovalova, Natalia; Nault, Rance; Crawford, Robert et al. (2017) Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells. Toxicol Appl Pharmacol 316:95-106
Li, Jinpeng; Phadnis-Moghe, Ashwini S; Crawford, Robert B et al. (2017) Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis. Toxicology 378:17-24
Phadnis-Moghe, Ashwini S; Li, Jinpeng; Crawford, Robert B et al. (2016) SHP-1 is directly activated by the aryl hydrocarbon receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Appl Pharmacol 310:41-50
Kovalova, Natalia; Manzan, Maria; Crawford, Robert et al. (2016) Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells. Toxicol Appl Pharmacol 309:15-23
Phadnis-Moghe, Ashwini S; Crawford, Robert B; Kaminski, Norbert E (2015) Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Toxicol Sci 144:39-50
Sulentic, Courtney E W; Kaminski, Norbert E (2011) The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 120 Suppl 1:S171-91
Lu, Haitian; Crawford, Robert B; Kaplan, Barbara L F et al. (2011) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells. Toxicol Appl Pharmacol 255:251-60
De Abrew, K Nadira; Phadnis, Ashwini S; Crawford, Robert B et al. (2011) Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 252:150-8

Showing the most recent 10 out of 30 publications